Coagulopathy in cirrhosis: A prospective study to correlate conventional tests of coagulation and bleeding following invasive procedures in cirrhotics
- 397 Downloads
Conventional tests of coagulation which only measure procoagulant factors do not correctly estimate the actual in vivo hemostatic balance in cirrhosis. This prospective multicenter study was conducted to evaluate safety of various invasive procedures in the presence of abnormal coagulation tests and to correlate conventional coagulation parameters with clinically significant bleeding in cirrhotics.
Three hundred and eighty patients (median age 54 years, 287 males) enrolled in the study were divided into two groups (A and B), according to the presence or absence of abnormal coagulation parameters (defined as INR ≥1.5 and/or platelet count ≤50,000/cum).
One hundred and twenty-eight patients (33.68 %) were qualified in group A. Alcohol was the predominant etiology of cirrhosis (40 % and 32 % in groups A and B, respectively). The two groups were similar in baseline characteristics other than tests of coagulation and severity of liver disease. Low risk procedures (abdominal paracentesis most common) were carried out in 47 % and 53 % patients in two groups, respectively. None of the patients in either group had clinically significant bleeding. Similarly, high risk procedures (central vein cannulation, liver biopsy, etc.) were carried out in 14 % and 10 %, respectively, in two groups. Three patients in group A developed clinically significant bleeding, however, the difference was statistically nonsignificant (p = 0.061). None of our patients received periprocedural correction of abnormal coagulation parameters with plasma/platelet concentrate.
Deranged conventional coagulation parameters did not predict clinically significant bleeding in cirrhosis. Whenever indicated, any invasive procedure could be safely carried out in patients with cirrhosis without prior correction of coagulation abnormalities.
KeywordsHemostasis Liver biopsy Paracentesis Procoagulant
Conflict of Interest
AS, DA, MD, MC, RB, PK, MJ, NP, PK, SG, NS, SK, and SD declare that they have no competing interests.
The study was performed in a manner to conform to the Helsinki Declaration of 1975, as revised in 2000 and 2008 concerning human and animal rights, and that the authors followed the policy concerning informed consent as shown on Springer.com
- 1.Tripodi A. Hemostasis abnormalities in chronic liver failure. In: Gines P, Kamath PS, Arroyo V, eds. Chronic Liver Failure: Mechanisms and Management. New York, NY: Springer; 2010. p. 289–303.Google Scholar
- 3.Tripodi A, Primignani M, Chantarangkul V, et al. An imbalance of pro- vs.-anti-coagulation factors in plasma from patients with cirrhosis. Gastroenterology. 2009;137:2105–11.Google Scholar
- 4.Tripodi A, Primignani M, Lemma L, et al. Detection of the imbalance of pro- vs. anti-coagulant factors in cirrhosis by a simple laboratory method. Hepatology. 2010;52:249–55.Google Scholar
- 7.Caldwell SH, Hoffman M, Lisman T, et al. Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management. Hepatology. 2006;44:1039–46.Google Scholar
- 8.Amarapurkar D. Optimal medical management of liver cirrhosis without liver transplant. In: Blackwell RM, Tyson AP, eds. Cirrhosis Causes, Treatment Options and Potential Complications. New York: Nova Science Publisher; 2014. p. 1–34.Google Scholar
- 9.Malloy PC, Grassi CJ, Kundu S, et al. Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. J Vasc Interv Radiol. 2009;20:240–9.Google Scholar
- 15.Grabau CM, Crago SF, Hoff LK, et al. Performance standards for therapeutic abdominal paracentesis. Hepatology. 2004;40:484–8.Google Scholar
- 18.da EC VR, D'Amico EA, Caldwell SH, et al. A prospective study of conventional and expanded coagulation indices in predicting ulcer bleeding after variceal band ligation. Clin Gastroenterol Hepatol. 2009;7:988–93.Google Scholar
- 21.Shah NL, Xavier E, Northup PG, et al. The use of thromboelastography, platelets, and INR in a clinical model for bleeding risk in cirrhotic patients. Gastroenterology. 2009;136:795.Google Scholar
- 23.Tripodi A, Salerno F, Chantarangkul V, et al. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology. 2005;41:553–8.Google Scholar
- 24.Tripodi A, Primignani M, Chantarangkul V, et al. Thrombin generation in patients with cirrhosis: the role of platelets. Hepatology. 2006;44:440–5.Google Scholar